Chundsell Medicals AB

CEO: Jan Erik CollinPrint

Web: chundsell.com

Chundsell Medicals AB was founded in 2007 as a spin off from CancerCenterkarolinska, Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics.

The first product: The Prostatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a since long used and well-known clinical parameters can help the health care professional to predict the disease outcome and the overall survival of newly diagnosed prostate cancer patients.

Share Button